PAHC Butterfly Strategy
PAHC (Phibro Animal Health Corporation), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries.
PAHC (Phibro Animal Health Corporation) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $1.43B, a trailing P/E of 15.01, a beta of 0.61 versus the broader market, a 52-week range of 22.51-60.08, average daily share volume of 326K, a public-listing history dating back to 2014, approximately 2K full-time employees. These structural characteristics shape how PAHC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.61 indicates PAHC has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. PAHC pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a butterfly on PAHC?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current PAHC snapshot
As of May 15, 2026, spot at $34.28, ATM IV 66.40%, IV rank 9.36%, expected move 19.04%. The butterfly on PAHC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this butterfly structure on PAHC specifically: PAHC IV at 66.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a PAHC butterfly, with a market-implied 1-standard-deviation move of approximately 19.04% (roughly $6.53 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PAHC expiries trade a higher absolute premium for lower per-day decay. Position sizing on PAHC should anchor to the underlying notional of $34.28 per share and to the trader's directional view on PAHC stock.
PAHC butterfly setup
The PAHC butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PAHC near $34.28, the first option leg uses a $32.57 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PAHC chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PAHC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $32.57 | N/A |
| Sell 2 | Call | $34.28 | N/A |
| Buy 1 | Call | $35.99 | N/A |
PAHC butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
PAHC butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on PAHC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on PAHC
Butterflies on PAHC are pinning bets - traders use them when they expect PAHC to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
PAHC thesis for this butterfly
The market-implied 1-standard-deviation range for PAHC extends from approximately $27.75 on the downside to $40.81 on the upside. A PAHC long call butterfly is a pinning play: it pays maximum at the middle strike if PAHC settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current PAHC IV rank near 9.36% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PAHC at 66.40%. As a Healthcare name, PAHC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PAHC-specific events.
PAHC butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PAHC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PAHC alongside the broader basket even when PAHC-specific fundamentals are unchanged. Always rebuild the position from current PAHC chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on PAHC?
- A butterfly on PAHC is the butterfly strategy applied to PAHC (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With PAHC stock trading near $34.28, the strikes shown on this page are snapped to the nearest listed PAHC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PAHC butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the PAHC butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 66.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PAHC butterfly?
- The breakeven for the PAHC butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PAHC market-implied 1-standard-deviation expected move is approximately 19.04%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on PAHC?
- Butterflies on PAHC are pinning bets - traders use them when they expect PAHC to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current PAHC implied volatility affect this butterfly?
- PAHC ATM IV is at 66.40% with IV rank near 9.36%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.